NCT04106219 2026-04-21A Study of LY3295668 Erbumine in Participants With Relapsed/Refractory NeuroblastomaEli Lilly and CompanyPhase 1 Active not recruiting71 enrolled
NCT05017025 2025-11-19Aurora Kinase Inhibitor LY3295668 in Combination With Osimertinib for the Treatment of Advanced or Metastatic EGFR-Mutant Non-squamous Non-small Cell Lung CancerM.D. Anderson Cancer CenterPhase 1/2 Active not recruiting32 enrolled